Diet and Parkinson's disease: A potential role of dairy products in men

Annals of Neurology

Volumn 52, Issue 6, 2002, Pages 793-801

  Chen, Honglei ^a   Zhang, Shumin M ^a,b   Hernán, Miguel A ^a   Willett, Walter C ^a,b   Ascherio, Alberto ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FAT; LACTOSE; PROTEIN; VITAMIN D;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DAIRY PRODUCT; DIET; DISEASE ASSOCIATION; EVALUATION; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK;

ADULT; AGED; COHORT STUDIES; CONFIDENCE INTERVALS; DAIRY PRODUCTS; DIET; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 0036895553     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10381     Document Type: Article

References (55)

1. Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: An etiologic study. JAMA 1999;281:341-346.
2. Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 1996;47(Suppl 3):S161-S170.
3. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044-1053.
4. Golbe LI, Farrell TM, Davis PH. Case-control study of early life dietary factors in Parkinson's disease. Arch Neurol 1988;45:1350-1353.
5. Morens DM, Grandinetti A, Waslien CI, et al. Case-control study of idiopathic Parkinson's disease and dietary vitamin E intake. Neurology 1996;46:1270-1274.
6. Logroscino G, Marder K, Cote L, et al. Dietary lipids and antioxidants in Parkinson's disease: A population-based, case-control study. Ann Neurol 1996;39:89-94.
7. Hellenbrand W, Boeing H, Robra BP, et al. Diet and Parkinson's disease. II. A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology 1996;47:644-650.
8. Scheider WL, Hershey LA, Vena JE, et al. Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease. Mov Disord 1997;12:190-196.
9. de Rijk MC, Breteler MM, den Breeijen JH, et al. Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol 1997;54:762-765.
10. Anderson C, Checkoway H, Franklin GM, et al. Dietary factors in Parkinson's disease: The role of food groups and specific foods. Mov Disord 1999;14:21-27.
11. Johnson CC, Gorell JM, Rybicki BA, et al. Adult nutrient intake as a risk factor for Parkinson's disease. Int J Epidemiol 1999;28:1102-1109.
12. Logroscino G, Marder K, Graziano J, et al. Dietary iron, animal fats, and risk of Parkinson's disease. Mov Disord 1998;13(suppl 1):13-16.
13. Davies KN, King D, Davies H. A study of the nutritional status of elderly patients with Parkinson's disease. Age Ageing 1994;23:142-145.
14. Hellenbrand W, Seidler A, Boeing H, et al. Diet and Parkinson's disease. I. A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology 1996;47:636-643.
15. Fall PA, Fredrikson M, Axelson O, et al. Nutritional and occupational factors influencing the risk of Parkinson's disease: A case-control study in southeastern Sweden. Mov Disord 1999;14:28-37.
16. Willett WC. Nutritional Epidemiology. 2nd Ed. New York: Oxford University, 1998.
17. Rimm EB, Giovannucci EL, Stampfer MJ, et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-1126; discussion, 1127-1136.
18. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-Year contribution to the understanding of health among women. J Womens Health 1997;6:49-62.
19. Ascherio A, Zhang SM, Hernán MA, et al. Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001;50:56-63.
20. US Department of Agriculture. Composition of Foods: Raw, Processed, Prepared, 1963-1988. Washington DC: US Department of Agriculture, 1989.
21. US Department of Agriculture, Agriculture Research Service. USDA Nutrient Database for Standard Reference. Release 10. Nutrient data laboratory home page. Available at http://www.nal.usda.gov/fnic/foodcomp, 1993.
22. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65.
23. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: The effects of week-to-week variation in food consumption. Int J Epidemiol 1989;18:858-867.
24. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790-796.
25. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65(suppl):1220S-1228S; discussion, 1229S-1231S.
26. Rothman KJ, Greenland S. Modern Epidemiology. 2nd Ed. Philadelphia: Lippincott, 1998.
27. D'Agostino RB, Lee ML, Belanger AJ, et al. Relation of pooled logistic regression to time dependent Cox regression analysis: The Framingham Heart Study. Stat Med 1990;9:1501-1515.
28. Koller WC, Langston JW, Hubble JP, et al. Does a long preclinical period occur in Parkinson's disease? Neurology 1991;41(suppl 2):8-13.
29. Mizuno Y, Hattori N, Matsumine H. Neurochemical and neurogenetic correlates of Parkinson's disease. J Neurochem 1998;71:893-902.
30. Greenamyre JT, MacKenzie G, Peng TI, et al. Mitochondrial dysfunction in Parkinson's disease. Biochem Soc Symp 1999;66:85-97.
31. Foley P, Riederer P. Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease. J Neurol 2000;247(suppl 2):II82-II94.
32. Betarbet R, Sherer TB, MacKenzie G, et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000;3:1301-1306.
33. Andersen SL, Gazzara RA, Robinson SR, et al. Effect of milk on dopamine release in the newborn rat: An in vivo microdialysis study. Brain Res Dev Brain Res 1992;68:286-288.
34. Andersen SL, Umphress SM, Robinson SR, et al. Modulation of dopamine binding in the fetal rat: Effects of milk and exogenous opioid manipulation. Pharmacol Biochem Behav 1993;46:377-381.
35. Kass GE, Wright JM, Nicotera P, et al. The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: Role of intracellular calcium. Arch Biochem Biophys 1988;260:789-797.
36. Damier P, Hirsch EC, Agid Y, et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999;122:1437-1448.
37. Damier P, Hirsch EC, Agid Y, et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 1999;122:1421-1436.
38. Shinpo K, Kikuchi S, Sasaki H, et al. Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine. J Neurosci Res 2000;62:374-382.
39. Ibi M, Sawada H, Nakanishi M, et al. Protective effects of lalpha,25-(OH)(2)D(3) against the neurotoxicicy of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 2001;40:761-771.
40. 3 attenuates 6-hydroxydopamin-induced neurocoxicity in rats. Brain Res 2001;904:67-75.
41. Nagatsu T. Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci Res 1997;29:99-111.
42. Makino Y, Ohta S, Tachikawa O, et al. Presence of tetrahydroiso-quinoline and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson's disease. Life Sci 1988;43:373-378.
43. Niwa T, Yoshizumi H, Tatematsu A, et al. Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods. J Chromatogr 1989;493:347-352.
44. Niwa T, Takeda N, Tatematsu A, et al. Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry. J Chromatogr 1988;452:85-91.
45. Nagatsu T, Yoshida M. An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 1988;87:178-182.
46. Yoshida M, Niwa T, Nagatsu T. Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: The behavioral and biochemical changes. Neurosci Lett 1990;119:109-113.
47. Kotake Y, Tasaki Y, Makino Y, et al. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: A novel endogenous amine in mouse brain and parkinsonian CSF. J Neurochem 1995;65:2633-2638.
48. Kotake Y, Yoshida M, Ogawa M, et al. Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate. Neurosci Lett 1996;217:69-71.
49. Bringmann G, God R, Feineis D, et al. The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons. J Neural Transm Suppl 1995;46:235-244.
50. Baker GB, Wong JT, Courts RT, et al. Simultaneous extraction and quantitation of several bioactive amines in cheese and chocolate. J Chromatogr 1987;392:317-331.
51. Novella-Rodriguez S, Veciana-Nogues MT, Vidal-Carou MC. Biogenic amines and polyamines in milks and cheeses by ionpair high performance liquid chromatography. J Agric Food Chem 2000;48:5117-5123.
52. Vale SR, Gloria MB. Determination of biogenic amines in cheese. J AOAC Int 1997;80:1006-1012.
53. Mariussen E, Fonnum F. The effect of polychlorinated biphenyls on the high affinity uptake of the neurotransmitters, dopamine, serotonin, glutamate and GABA, into rat brain synaptosomes. Toxicology 2001;159:11-21.
54. Mariussen E, Morch Andersen J, Fonnum F. The effect of polychlorinated biphenyls on the uptake of dopamine and other neurotransmitters into rat brain synaptic vesicles. Toxicol Appl Pharmacol 1999;161:274-282.
55. Benedetti MD, Bower JH, Maraganore DM, et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology 2000;55:1350-1358.